WuXi Healthcare Ventures logo

WuXi Healthcare Ventures

North America, Massachusetts, United States, Cambridge

Description

WuXi Healthcare Ventures is a Chinese investment firm that helps life sciences companies to develop transformative therapies.

Investor Profile

WuXi Healthcare Ventures has made 39 investments, with 0 in the past 12 months and 15% as lead.

Stage Focus

  • Series B (36%)
  • Series A (33%)
  • Series C (15%)
  • Series D (8%)
  • Series Unknown (5%)
  • Series E (3%)

Country Focus

  • United States (64%)
  • China (33%)
  • Israel (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Life Science
  • Genetics
  • Oncology
  • Medical Device
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does WuXi Healthcare Ventures frequently co-invest with?

Alexandria
North America, California, United States, San Francisco
Co-Investments: 3
Frontline BioVentures
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 5
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 4
Ally Bridge Group
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 3
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
6 Dimensions Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 4
Venrock
North America, California, United States, Palo Alto
Co-Investments: 5
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 9
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 5

Which angels does WuXi Healthcare Ventures often collaborate with?

Shared Deals: 1
RK
North America, California, United States
Shared Deals: 1
BN
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by WuXi Healthcare Ventures?

Adlai Nortye

Hangzhou, Zhejiang, China

Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types.

BiotechnologyHealth CareOncologyPharmaceutical
Series DJul 13, 2021
Amount Raised: $100,000,000
Zenas BioPharma

Waltham, Massachusetts, United States

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

BiopharmaHealth CarePharmaceutical
Series AMar 23, 2021
LifeMine Therapeutics

Cambridge, Massachusetts, United States

LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.

BiotechnologyGeneticsLife ScienceTherapeutics
Series BJan 7, 2021
Amount Raised: $50,000,000
XW Laboratories

Wuhan, Hubei, China

XW Laboratories develops a portfolio of internally discovered product candidates for the potential treatment of neurological disorders.

BiotechnologyHealth CarePharmaceutical
Series CSep 18, 2020
Amount Raised: $40,000,000
Halda Therapeutics

New Haven, Connecticut, United States

Halda Therapeutics is a research-stage drug discovery company.

BiotechnologyMedicalTherapeutics
Series AFeb 1, 2019
Amount Raised: $25,000,000
Antengene Corporation

Shanghai, Shanghai, China

Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.

BiopharmaBiotechnologyLife SciencePharmaceutical
Series BJan 2, 2019
Amount Raised: $120,000,000
Refuge Biotechnologies

Menlo Park, California, United States

Refuge Biotechnologies therapeutic company focused on gene editing and genetic engineering of immune cells for cancer immunotherapy.

BiotechnologyGeneticsHealth CareTherapeutics
Series BMay 2, 2018
Amount Raised: $25,000,000
UNITY Biotechnology

South San Francisco, California, United States

Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging.

BiotechnologyHealth CareMedical
Series CMar 19, 2018
Amount Raised: $55,000,000
IDEAYA Biosciences

South San Francisco, California, United States

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

BiotechnologyHealth CareOncologyTherapeutics
Series BMar 15, 2018
Amount Raised: $94,000,000
Medeor Therapeutics

South San Francisco, California, United States

Medeor Therapeutics is a biotechnology company that dedicates to dedicates to the development of personalized cellular immunotherapies.

BiotechnologyPharmaceuticalTherapeutics
Series BNov 27, 2017
Amount Raised: $57,000,000